Psilocybin - eine neue psychotrope Substanz
W. de Borr
DMW - Deutsche Medizinische Wochenschrift July 1, 1959 DOI: 10.1055/s-0028-1114457 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional study Peer reviewed |
|---|---|
| Sample size | 1,042 |
| Population | Patients with chronic kidney disease in general practice |
| Topics | Psilocybin |
| Keywords | Pharmacology |
| Citations | 1 |
| Key findings | Many patients with CKD receive prescriptions that may be inappropriate or require dose adjustment for their kidney function. |
Abstract
Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study
Comparable studies
Other cross-sectional and survey studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Individuals who had consumed psilocybin mushrooms and experienced a psychologically... | 2016 | Cross-sectional survey | n = 1,993 |
| The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin | 2016 | Questionnaire development and validation | |
| Psychedelics and Mental Health: A Population Study Adult population in the United States | 2013 | Cross-sectional survey | n = 130,152 |
| Cessation and reduction in alcohol consumption and misuse after psychedelic use Individuals with prior alcohol use disorder who reported cessation or reduction in... | 2019 | Cross-sectional survey | n = 343 |
| Patterns of simultaneous polysubstance use in drug using university students Drug-using university students | 2006 | Cross-sectional survey | n = 149 |